Yamashita Motoyasu, Fukushima Setsu, Shen Hao-wei, Hall F Scott, Uhl George R, Numachi Yohtaro, Kobayashi Hideaki, Sora Ichiro
Department of Psychobiology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Neuropsychopharmacology. 2006 Oct;31(10):2132-9. doi: 10.1038/sj.npp.1301009. Epub 2006 Jan 11.
Dopamine transporter knockout (DAT KO) mice display deficits in sensorimotor gating that are manifested by reduced prepulse inhibition (PPI) of the acoustic startle reflex. Since PPI deficits may model some of the cognitive dysfunctions identified in certain neuropsychiatric patients, we have studied the effects of transporter blockers on PPI in wild-type and DAT KO mice. Treatments with High dose psychostimulants that block DAT as well as the norepinephrine (NET) and serotonin (SERT) transporters (60 mg/kg cocaine or methylphenidate) significantly impaired PPI in wild-type mice. By contrast, these treatments significantly ameliorated the PPI deficits observed in untreated DAT KO mice. In studies with more selective transport inhibitors, the selective NET inhibitor nisoxetine (10 or 30 mg/kg) also significantly reversed PPI deficits in DAT KO mice. By contrast, while the SERT inhibitor fluoxetine (30 mg/kg) normalized these PPI deficits in DAT KO mice, citalopram (30 or 100 mg/kg) failed to do so. The 'paradoxical' effects of cocaine and methylphenidate in DAT KO mice are thus likely to be mediated, at least in part by the ability of these drugs to block NET, although serotonin systems may also have some role. Together with recent microdialysis data, these results support the hypothesis that prefrontal cortical NET blockade and consequent enhancement of prefrontal cortical extracellular dopamine mediates the reversal of PPI deficits in DAT KO mice.
多巴胺转运体基因敲除(DAT KO)小鼠表现出感觉运动门控缺陷,这表现为听觉惊吓反射的前脉冲抑制(PPI)降低。由于PPI缺陷可能模拟某些神经精神疾病患者中发现的一些认知功能障碍,我们研究了转运体阻滞剂对野生型和DAT KO小鼠PPI的影响。高剂量阻断DAT以及去甲肾上腺素(NET)和5-羟色胺(SERT)转运体的精神兴奋剂(60mg/kg可卡因或哌醋甲酯)治疗显著损害了野生型小鼠的PPI。相比之下,这些治疗显著改善了未治疗的DAT KO小鼠中观察到的PPI缺陷。在使用更具选择性的转运抑制剂的研究中,选择性NET抑制剂尼索西汀(10或30mg/kg)也显著逆转了DAT KO小鼠的PPI缺陷。相比之下,虽然SERT抑制剂氟西汀(30mg/kg)使DAT KO小鼠的这些PPI缺陷恢复正常,但西酞普兰(30或100mg/kg)却未能做到。因此,可卡因和哌醋甲酯在DAT KO小鼠中的“矛盾”作用可能至少部分是由这些药物阻断NET的能力介导的,尽管5-羟色胺系统可能也有一定作用。与最近的微透析数据一起,这些结果支持了以下假设:前额叶皮质NET阻断以及随之而来的前额叶皮质细胞外多巴胺的增强介导了DAT KO小鼠中PPI缺陷的逆转。